Non-Pharmacologic Treatment of Rosacea
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage for non-pharmacologic treatments for rosacea (e.g., laser and light therapy, dermabrasion, chemical peels, surgical debulking, electrosurgery) for Blue Cross Blue Shield - North Carolina members and guidance for providers on billing and documentation.
No material clinical or coverage changes in this revision.
Coverage Determination and Criteria
Coverage determination
Covered when ALL of the following are met:
BCBSNC does not cover investigational services.
Refer to policy guidelines for evidence summary indicating insufficient evidence of net health benefit.
No randomized trials identified for other nonpharmacologic treatments; additional RCTs comparing to placebo and pharmacologic treatments are needed.
Non‑pharmacologic treatments that have been used for rosacea include laser and light therapy, dermabrasion, chemical peels, surgical debulking, and electrosurgery. These procedures are typically aimed at reducing visible blood vessels, persistent facial erythema, or tissue overgrowth (e.g., rhinophyma) when medical therapy is insufficient or for cosmetic improvement.
This policy designates non‑pharmacologic treatment of rosacea as investigational and therefore not covered by BCBSNC. Because the services are classified investigational, they are excluded from coverage rather than being listed under a not‑medically‑necessary category.
Billing and Coding
Provider Billing, Documentation, and Authorization
Applicable service codes — prior review may be required
Inclusion of a code in the Billing/Coding section does not guarantee reimbursement; BCBSNC may require review and documentation for medical necessity and may request records when determining coverage. See billing/coding guidance and Administrative Policies on the BCBSNC website for reimbursement rules.
Prepare full supporting documentation on request
BCBSNC may request additional provider information or records when evaluating services; letters of support/explanation can help but are not sufficient by themselves unless they include all information needed for medical necessity review.
- Prepare to submit full clinical documentation if requested
- Letters of support/explanation are often useful but are not sufficient documentation unless they include all specific information needed to make a medical necessity determination
Medical record request — include all required clinical details
When BCBSNC requests medical records for determination of medical necessity, include all specific clinical information needed to make the determination; do not rely on letters alone.
- BCBSNC may request medical records for determination of medical necessity
- Letters of support and/or explanation are often useful but are not sufficient documentation unless all specific information needed to make a medical necessity determination is included
Denial risk — non‑pharmacologic rosacea treatments investigational
Non‑pharmacologic treatments for rosacea (including but not limited to laser and light therapy, dermabrasion, chemical peels, surgical debulking and electrosurgery) are considered investigational and BCBSNC does not cover investigational services; claims for these services may be denied.
- Examples of non‑pharmacologic treatments deemed investigational: laser and light therapy, dermabrasion, chemical peels, surgical debulking, electrosurgery
- Do not expect coverage; submit only when prior review/authorization indicates coverage—otherwise claims may be denied
Background
Rosacea is a chronic dermatologic condition that commonly causes episodic facial erythema, flushing, edema, papules and pustules, and visible telangiectasias. Symptoms often persist or recur over time and can lead to persistent redness and tissue changes if not managed. Management typically involves pharmacologic therapies; procedural interventions have been used for cosmetic or refractory manifestations but are considered investigational in this policy.
Definitions and Examples
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.